Address And Details

32 Old Slip , New York, NY 10005
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The Goldman Sachs Small/Mid Cap Growth Fund (the Fund ) seeks long-term growth of capital. The Fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) ( Net Assets ) in a diversified portfolio of equity investments in small and mid-cap issuers. Small or mid-cap issuers are issuers with public stock market capitalizations (based upon shares available for trading on an unrestricted basis) within the outside range of the market capitalizations of companies constituting the Russell 2000 Growth Index and the Russell Midcap Growth Index, as last reported by the indexes prior to the time of investment. If the market capitalization of a company held by the Fund moves outside this range, the Fund may, but is not required to, sell the securities. As of September 30, 2020, the outside capitalization range of the companies in these indexes was between $188 million and $24 billion. The Fund seeks to achieve its investment objective by investing, under normal circumstances, in companies that are considered by the Investment Adviser to be positioned for long-term growth. Although the Fund invests primarily in publicly traded U.S. securities, it may invest up to 25% of its Net Assets in foreign securities, including securities of issuers in countries with emerging markets or economies ( emerging countries ) and securities quoted in foreign currencies. The Fund may also invest in privately held companies and companies that only recently began to trade publicly. The Fund s fundamental equity growth investment process involves evaluating potential investments based on specific characteristics believed to indicate a high-quality business with sustainable growth, including strong business franchises, favorable long-term prospects, and excellent management. The Investment Adviser will also consider valuation of companies when determining whether to buy and/or sell securities. The Investment Adviser may integrate environmental, social and governance ( ESG ) factors with traditional fundamental factors as part of its fundamental research process. No one factor or consideration is determinative in the stock selection process. The Investment Adviser may decide to sell a position for various reasons, including when a company s fundamental outlook deteriorates, because of valuation and price considerations, for risk management purposes, or when a company is deemed to be misallocating capital or a company no longer fits within the Fund s definition of a small/mid cap company. In addition, the Investment Adviser may sell a position in order to meet shareholder redemptions. The Fund may invest up to 20% of its Net Assets in fixed income securities, such as government, corporate and bank debt obligations. The Fund s benchmark index is the Russell 2500 Growth Index.

Net Asset Value

as of 6:03 PM ET 09/17/2021


  • 1 Week
  • +0.71%
  • 1 Month
  • +6.77%
  • 3 Months
  • +6.94%
  • 1 Yr Return
  • +22.71%
  • 5 Yr Return
  • +41.54%

Equity Sector Breakdown

Technology 26.63%
IndustrialCyclical 18.00%
Health 15.68%
Services 10.28%
NonDurables 8.41%
RetailTrade 8.36%
Finance 5.47%
ConsumerDurables 2.86%
Energy n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 98.79%
Other 1.27%
ForeignStocks 1.09%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 23.51 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 4.76 3.07 0.52
Beta 1.08 1.07 1.08
R Squared 0.78 0.76 0.75
Std Deviation 22.58 18.31 16.78
Sharpe Ratio 1.15 1.25 n/a

Purchase Information

as of 6:16 PM ET 09/16/2021
Minimum Initial $0
Minimum Additional $0
Minimum Initial IRA $0


Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +38.78%
  • +47.36%
+38.78% +47.36%
3 Year
  • +24.32%
  • +25.75%
+24.32% +25.75%
10 Year
  • +17.81%
  • +16.05%
+17.81% +16.05%
Life Of Fund
  • +13.45%
  • +13.35%
+13.45% +13.35%

Top 10 Holdings

Symbol Company Name % Of Assets
RH RH 1.62%

Recent Articles from TheStreet

Toys 'R' Us Sells FAO Schwarz as it Reveals Further Debt Refinancing Plans

Toymakers Facing Holiday Challenge Due to Supply-Chain Issues

Supply-chain issues could make this Christmas season more challenging than normal for toymakers, a media report says.

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Twitter Blue Lead

Twitter to Pay $810M to Settle Holder Suit Over User Engagement

Twitter's payment would settle a shareholder lawsuit that the company misled investors about its user engagement totals.

Starboard Takes Stake in CVS Health Corp.: Report

CVS to Add 25,000 Workers Ahead of Flu Season, Covid Booster Shots

Pharmacy giant CVS plans to add 25,000 ahead of flu season and coronavirus-related vaccinations.

Chinese Investors Mock Asset Managers And Offer Advice On Stock Picks For Cautious Approach To Renewables Sector

Stocks May Drop 20% as Stimulus Eases, Growth Slows: Morgan Stanley

Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.

Watch Jim Cramer Live 9/20

Video: Jim Cramer on the Market Selloff, Evergrande, Debt Ceiling, Fed, Pfizer

Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.